SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001654954-19-000853
Filing Date
2019-01-29
Accepted
2019-01-29 15:44:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sc13g_balk.htm SC 13G/A 89088
  Complete submission text file 0001654954-19-000853.txt   90404
Mailing Address 229 WEST 60TH STREET NEW YORK NY 10023
Business Address
BALK MATTHEW (Filed by) CIK: 0001217674 (see all company filings)

Type: SC 13G/A

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Subject) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A | Act: 34 | File No.: 005-89966 | Film No.: 19548624
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1